Pharmaceutics International has filed a notice of an exempt offering of securities to raise $4,249,989.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Pharmaceutics International is raising up to $4,249,989.00 in new funding. Sources indicate that as part of senior management Chairman, Syed Abidi played a key role in securing the recent investment.
About Pharmaceutics International
Pharmaceutics International, Inc. (Pii) is a science-driven contract development and manufacturing organization (CDMO) with a single campus in Hunt Valley, MD USA, offering unparalleled scientific insight and depth of product knowledge while supplying high-quality dosage forms that enhance the lives of patients worldwide. Founded in 1994, Pii has grown from 12 employees to over 280 scientists and support staff and over 360,000 square feet of space in the U.S. Piis cGMP facilities are state-of-the-art and contain over 70 manufacturing rooms as well as containment suites for handling high potency compounds and hormones, dedicated manufacturing suites for oral products (e.g. soft gels) and injectables (e.g. vials and syringes), a formulation development center and state-of-the-art analytical laboratories.
To learn more about Pharmaceutics International, visit http://pharm-int.com/
Contact:
Syed Abidi, Chairman
410-584-0001
https://www.linkedin.com/in/syed-abidi-95002b42/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.